(FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | (FY)Dec 31, 2018 | (FY)Dec 31, 2017 | |
---|---|---|---|---|---|---|---|---|
Turnover | -54.94%19.7B | -46.76%8.46B | -6.26%43.72B | --15.89B | 31.30%46.64B | 149.87%35.52B | 125.88%14.22B | --6.29B |
Operating income | -54.94%19.7B | -46.76%8.46B | -6.26%43.72B | 15.89B | 31.30%46.64B | 149.87%35.52B | 125.88%14.22B | 6.29B |
Cost of sales | 53.95%-17.96B | 41.97%-7.56B | -2.12%-39.01B | ---13.03B | -41.29%-38.2B | -141.08%-27.04B | -105.44%-11.22B | ---5.46B |
Operating expenses | 53.95%-17.96B | 41.97%-7.56B | -2.12%-39.01B | -13.03B | -41.29%-38.2B | -141.08%-27.04B | -105.44%-11.22B | -5.46B |
Gross profit | -63.09%1.74B | -68.57%900.38M | -44.20%4.71B | 2.86B | -0.53%8.43B | 182.75%8.48B | 259.69%3B | 833.83M |
Selling expenses | 50.65%-625.22M | 37.28%-386.63M | -2.14%-1.27B | ---616.41M | -15.50%-1.24B | -42.62%-1.07B | -49.84%-752.99M | ---502.52M |
Administrative expenses | 48.77%-505.84M | 31.09%-324.13M | 12.80%-987.35M | ---470.37M | -0.60%-1.13B | -0.57%-1.13B | -114.49%-1.12B | ---521.75M |
Revaluation surplus | -361.75%-46.4M | ---- | 283.35%17.73M | --14.83M | -79.36%4.62M | 60.29%22.41M | -19.13%13.98M | --17.29M |
-Changes in the fair value of investment property | -361.75%-46.4M | ---- | 283.35%17.73M | --14.83M | -79.36%4.62M | 60.29%22.41M | -19.13%13.98M | --17.29M |
Impairment and provision | -249.01%-513.09M | ---- | ---147.01M | ---- | ---- | ---- | ---- | ---- |
-Other impairment is provision | -249.01%-513.09M | ---- | ---147.01M | ---- | ---- | ---- | ---- | ---- |
Operating interest expense | -23.07%-1.55B | 50.64%-228.66M | -12.93%-1.26B | ---463.24M | -43.19%-1.11B | ---777.57M | ---- | ---- |
Special items of operating profit | -1,443.13%-1.74B | -480.29%-121.42M | 56.00%129.75M | --31.93M | 73.69%83.17M | 24.27%47.89M | -62.14%38.54M | --101.77M |
Operating profit | -371.38%-3.24B | -111.78%-160.46M | -76.27%1.2B | 1.36B | -9.63%5.04B | 372.49%5.57B | 1,752.39%1.18B | -71.39M |
Financing cost | ---- | ---- | ---- | ---- | ---- | ---- | -96.13%-432.11M | ---220.32M |
Share of profits of associates | -47.92%49.77M | -1,117.87%-17.09M | 583.37%95.56M | --1.68M | -271.88%-19.77M | 137.19%11.5M | -2,192.74%-30.93M | ---1.35M |
Share of profit from joint venture company | -118.18%-63.47M | -106.54%-15.88M | 17,135.14%349.18M | --243M | 103.71%2.03M | -79.21%-54.64M | -2,624.17%-30.49M | --1.21M |
Earning before tax | -298.61%-3.26B | -112.04%-193.43M | -67.33%1.64B | 1.61B | -9.25%5.02B | 706.10%5.53B | 335.08%686.06M | -291.84M |
Tax | 42.25%-669.47M | 32.30%-428.7M | 41.02%-1.16B | ---633.25M | 15.33%-1.97B | -799.34%-2.32B | -4,478.66%-258.12M | --5.9M |
After-tax profit from continuing operations | -916.89%-3.93B | -163.93%-622.13M | -84.26%480.68M | 973.11M | -4.85%3.05B | 649.86%3.21B | 249.66%427.94M | -285.95M |
Earning after tax | -916.89%-3.93B | -163.93%-622.13M | -84.26%480.68M | 973.11M | -4.85%3.05B | 649.86%3.21B | 249.66%427.94M | -285.95M |
Minority profit | -106.89%-47.95M | -91.05%39.45M | 70.86%696.04M | --440.78M | -54.57%407.37M | 771.46%896.67M | 625.93%102.89M | --14.17M |
Profit attributable to shareholders | -1,700.97%-3.88B | -224.28%-661.58M | -108.14%-215.36M | 532.33M | 14.43%2.65B | 611.37%2.31B | 208.30%325.05M | -300.12M |
Basic earnings per share | -1,714.29%-1.27 | -229.41%-0.22 | -106.54%-0.07 | 0.17 | 11.46%1.07 | 0.96 | ||
Diluted earnings per share | -1,714.29%-1.27 | -229.41%-0.22 | -106.54%-0.07 | 0.17 | 11.46%1.07 | 0.96 | ||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | -- | -- | -- | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion |
Auditor | -- | -- | -- | -- | Ernst & Young | Ernst & Young | Ernst & Young | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data